THRX

Theravance, Inc. News Headlines

$23.03
*  
0.19
0.82%
Get THRX Alerts
*Delayed - data as of Aug. 27, 2014  -  Find a broker to begin trading THRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    THRX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Weekly CEO Sells Highlight: Texas Roadhouse Inc., Theravance Inc., AmerisourceBergen Corp. ...
5/6/2013 6:23:28 PM - GuruFocus

Weekly CFO Sells Highlight: THRX, BERY, IPG, PG, ZNGA, TSS
5/5/2013 5:21:04 PM - GuruFocus

Split News Overshadows Theravance's 1Q Loss - Analyst Blog
4/26/2013 5:21:50 PM - Zacks.com

Mid-Morning Market Update: Markets Open Mixed, Chevron Profit Beats Estimates
4/26/2013 10:20:48 AM - Benzinga

5 Stocks To Watch Next Week For Gains
4/20/2013 1:47:00 AM - Seeking Alpha

FDA Panel Backs GSK/THRX's Drug - Analyst Blog
4/18/2013 5:12:49 PM - Zacks.com

Mid-Afternoon Market Update: Fairway Group Rises on Successful IPO as Markets Fall Further
4/18/2013 3:43:57 PM - Benzinga

Mid-Day Market Update: Ultratech Tumbles On Downbeat Results, Theravance Rises
4/18/2013 1:11:30 PM - Benzinga

Mid-Morning Market Update: Markets Go Red, PepsiCo Profit Beats Estimates
4/18/2013 10:42:30 AM - Benzinga

Benzinga Market Primer: Thursday, April 18
4/18/2013 6:33:48 AM - Benzinga

GSK/THRX Drug to Face FDA Panel - Analyst Blog
4/16/2013 5:00:01 PM - Zacks.com

Don't Believe The Stories That The Markets Are Down Today
4/16/2013 7:58:00 AM - Seeking Alpha

3 Healthcare Stocks Waiting For The FDA's Approval
4/5/2013 3:58:00 PM - Seeking Alpha

Why This Pharma Is A Buy Despite Expected Dip
3/14/2013 11:37:00 AM - Seeking Alpha

Baupost Group 13F Holdings Analysis
3/7/2013 3:05:00 PM - Seeking Alpha

Buyout Speculation Drives Up Theravance Ahead Of FDA Advisory Committee Meeting
3/6/2013 7:31:00 PM - Seeking Alpha

Theravance's Drug Breo Likely To Receive FDA Approval
3/4/2013 5:47:00 PM - Seeking Alpha

Glaxo/Theravance Seek US Approval - Analyst Blog
2/21/2013 5:00:01 PM - Zacks.com

Seth Klarman's Top Stock Picks
2/20/2013 7:21:00 PM - Seeking Alpha

Upcoming FDA Approval Decision Dates For Q2 2013
2/15/2013 1:43:00 PM - Seeking Alpha

Theravance, Inc. Has Upcoming Catalysts And Long-Term Potential
2/14/2013 4:10:00 PM - Seeking Alpha

Tracking Seth Klarman's Baupost Group Holdings - Q4 2012 Update
2/14/2013 3:58:00 AM - Seeking Alpha

Seth Klarman's Baupost Group Buys AIG, Idenix Pharmaceuticals, Sells Hewlett-Packard, Oracle, ...
2/13/2013 7:44:46 PM - GuruFocus

Theravance Narrows Y/Y Loss - Analyst Blog
2/13/2013 10:41:01 AM - Zacks.com

2 Biotech Stocks With Upcoming Catalysts
2/4/2013 7:54:00 PM - Seeking Alpha